Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cellectis Sees Independent Future After Pfizer Deal
TheStreet.com
Monday, June 23, 2014 - 6:21pm
tags:
Cellectis, Pfizer, chimeric antigen receptor T-cell immunotherapies
Cubist Sivextro sales to benefit from lack of warnings, says JMP Securities
The Fly on the Wall
Monday, June 23, 2014 - 12:53pm
tags:
Sivextro, antibiotics, Cubist Pharmaceuticals
Some cancer docs still bill heavily for Amgen's Epogen despite safety questions
Fierce Pharma
Monday, June 23, 2014 - 12:53pm
tags:
Amgen, Epogen, anemia, Procrit, JNJ
FDA cuts back oversight of medical device data systems
Mass Device
Monday, June 23, 2014 - 12:44pm
tags:
FDA, devices
Allergan, Valeant trade rapid-fire salvos in ongoing takeover battle
Marketwatch
Monday, June 23, 2014 - 11:36am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Aerie's Upcoming Catalyst - ROCKing The Way To Success
Seeking Alpha
Monday, June 23, 2014 - 11:36am
tags:
Aerie Pharma, glaucoma, Roclatan, Rhopressa, Novartis, Pfizer, Allergan
23andMe Is Moving Forward In The FDA Approval Process
Yahoo/Business Insider
Monday, June 23, 2014 - 10:19am
tags:
23andMe, FDA, diagnostics
Can pharma salvage its tarnished reputation? Survey says yes
Fierce Pharma
Monday, June 23, 2014 - 10:18am
tags:
pharma industry
Allergan advises shareholders against Valeant tender offer
Yahoo/Reuters
Monday, June 23, 2014 - 10:00am
tags:
Allergan, Valeant Pharmaceuticals, M&A
As Google, Apple Get Ready To Change Mobile Health, Some Advertisers Could Find The FDA Barring The Way
Forbes
Monday, June 23, 2014 - 9:59am
tags:
mHealth, Apple, Google, FDA
U.S. Steps Up Probes of Deals to Block Generic Drugs
Yahoo/Bloomberg
Monday, June 23, 2014 - 9:52am
tags:
generics, FTC
[video]FDA Drops the Hammer on Twitter
Motley Fool
Monday, June 23, 2014 - 9:51am
tags:
twitter, FDA, social media
FDA staff question validity of benefit seen with AstraZeneca drug
Yahoo/Reuters
Monday, June 23, 2014 - 9:42am
tags:
FDA, AstraZeneca, olaparib, ovarian cancer
AbbVie Raises Outlook on Strong Performance Amid Shire Offer
Bloomberg
Monday, June 23, 2014 - 9:41am
tags:
AbbVie, Shire, M&A, guidance
Pfizer Arthritis drug leads to full head of hair
CNBC
Monday, June 23, 2014 - 9:40am
tags:
Pfizer, alopecia, rheumatoid arthritis, Xeljanz
AbbVie’s Gonzalez Seeks Quick Diversity With Shire Offer
Bloomberg
Monday, June 23, 2014 - 9:39am
tags:
AbbVie, Richard Gonzalez, Shire, M&A, diversification
Shire to set out AstraZeneca-style defense against AbbVie
Yahoo/Reuters
Monday, June 23, 2014 - 9:37am
tags:
Shire, Pfizer, M&A, AstraZeneca, AbbVie
Johnson & Johnson: Expect Dividend Growth To Accelerate In Next 2 Years
Seeking Alpha
Sunday, June 22, 2014 - 9:22am
tags:
JNJ
Verastem Inc.'s Upcoming Catalysts
Motley Fool
Sunday, June 22, 2014 - 9:20am
tags:
Verastem
What Big Pharma Could Learn From A Craft Beer Brewer
Forbes
Saturday, June 21, 2014 - 11:58am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.